Detection of large deletions in the LDL receptor gene with quantitative PCR methods

被引:12
作者
Damgaard, D
Nissen, PH
Jensen, LG
Nielsen, GG
Stenderup, A
Larsen, ML
Faergeman, O
机构
[1] Aarhus Univ Hosp, Dept Med & Cardiol, Aarhus Sygehus, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Aarhus Sygehus, Dept Clin Biochem, Aarhus, Denmark
[3] Aarhus Univ Hosp, Dept Clin Genet, Aarhus Sygehus, Aarhus, Denmark
关键词
D O I
10.1186/1471-2350-6-15
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Familial Hypercholesterolemia (FH) is a common genetic disease and at the molecular level most often due to mutations in the LDL receptor gene. In genetically heterogeneous populations, major structural rearrangements account for about 5% of patients with LDL receptor gene mutations. Methods: In this study we tested the ability of two different quantitative PCR methods, i.e. Real-Time PCR and Multiplex Ligation-Dependent Probe Amplification (MLPA), to detect deletions in the LDL receptor gene. We also reassessed the contribution of major structural rearrangements to the mutational spectrum of the LDL receptor gene in Denmark. Results: With both methods it was possible to discriminate between one and two copies of the LDL receptor gene exon 5, but the MLPA method was cheaper, and it was far more accurate and precise than Real-Time PCR. In five of 318 patients with an FH phenotype, MLPA analysis revealed five different deletions in the LDL receptor gene. Conclusion: The MLPA method was accurate, precise and at the same time effective in screening a large number of FH patients for large deletions in the LDL receptor gene.
引用
收藏
页数:7
相关论文
共 23 条
[1]   The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population [J].
Damgaard, D ;
Larsen, ML ;
Nissen, PH ;
Jensen, JA ;
Jensen, HK ;
Soerensen, VR ;
Jensen, LG ;
Faergeman, O .
ATHEROSCLEROSIS, 2005, 180 (01) :155-160
[2]   Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay [J].
De Preter, K ;
Speleman, F ;
Combaret, V ;
Lunec, J ;
Laureys, G ;
Eussen, BHJ ;
Francotte, N ;
Board, J ;
Pearson, ADJ ;
De Paepe, A ;
Van Roy, N ;
Vandesompele, J .
MODERN PATHOLOGY, 2002, 15 (02) :159-166
[3]   The molecular basis of familial hypercholesterolemia in The Netherlands [J].
Fouchier, SW ;
Defesche, JC ;
Umans-Eckenhausen, MAW ;
Kastelein, JJP .
HUMAN GENETICS, 2001, 109 (06) :602-615
[4]   Quantitative RT-PCR: Pitfalls and potential [J].
Freeman, WM ;
Walker, SJ ;
Vrana, KE .
BIOTECHNIQUES, 1999, 26 (01) :112-+
[5]   Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach [J].
Gille, JJP ;
Hogervorst, FBL ;
Pals, G ;
Wijnen, JT ;
van Schooten, RJ ;
Dommering, CJ ;
Meijer, GA ;
Craanen, ME ;
Nederlof, PM ;
de Jong, D ;
McElgunn, CJ ;
Schouten, JP ;
Menko, FH .
BRITISH JOURNAL OF CANCER, 2002, 87 (08) :892-897
[6]  
GOLDSTEIN JL, 2001, METABOLIC MOL BASIS
[7]   Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis [J].
Heath, KE ;
Gahan, M ;
Whittall, RA ;
Humphries, SE .
ATHEROSCLEROSIS, 2001, 154 (01) :243-246
[8]  
Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602
[9]   Spectrum of LDL receptor gene mutations in Denmark:: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia [J].
Jensen, HK ;
Jensen, LG ;
Meinertz, H ;
Hansen, PS ;
Gregersen, N ;
Færgeman, O .
ATHEROSCLEROSIS, 1999, 146 (02) :337-344
[10]   Rapid identification of female carriers of DMD/BMD by quantitative real-time PCR [J].
Joncourt, F ;
Neuhaus, B ;
Jostarndt-Foegen, K ;
Kleinle, S ;
Steiner, B ;
Gallati, S .
HUMAN MUTATION, 2004, 23 (04) :385-391